Key facts
- cheMastery’s last known valuation is $19.4M (Jan 2026).
- It has raised $5.0M; the latest was Seed Round ($1.9M) in Jan 2026.
- Notable investors include Entrepreneurs First, 7percent Ventures, WCS Nominees, Empirical Ventures, Formic Ventures — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for cheMastery
- ·The full record, as it builds
Funding rounds
No funding rounds for cheMastery are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About cheMastery
Developer of an automation technology company designed to build the infrastructure for chemistry. The company's technology provides automation systems for chemical laboratories to facilitate the manufacturing, research, and development processes, enabling scientists in the chemical industry to generate research.
- Sector
- Healthcare
- HQ
- Ilford, United Kingdom
- Founded
- 2019
- Employees
- 8
- Website
- chemastery.com/
- Ownership
- Privately Held (backing)
cheMastery doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in cheMastery shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on cheMastery in its N-PORT filings yet. We sweep new filings monthly.